CVE:VM

Voyageur Pharmaceuticals Stock Forecast, Price & News

C$0.10

+0.01 (+5.56 %)

(As of 07/30/2021 03:54 PM ET)

Add

Compare

Today's Range

C$0.09

▼

C$0.10

50-Day Range

C$0.09

▼

C$0.16

52-Week Range

C$0.04

▼

C$0.35

Volume167,000 shs

Average Volume204,333 shs

Market CapitalizationC$9.57 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive VM News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast
April 6, 2021 | theglobeandmail.com

Pharma Stock Pops After Receiving Approval From Health Canada (HC)
April 5, 2021 | baystreet.ca

Voyageur, Arbor, BevCanna at 52-Week Highs on News
December 29, 2020 | baystreet.ca

Japan Asset Marketing Co.,Ltd. Stock , JASSF
December 26, 2020 | markets.businessinsider.com

Voyageur Minerals' Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration
October 20, 2020 | theglobeandmail.com

Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada
June 15, 2020 | www.bloomberg.com

Voyageur Pharmaceuticals Ltd.
May 23, 2020 | www.barrons.com

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development
May 11, 2020 | www.benzinga.com

Voyageur Restructures its ImagingX Joint Venture
March 20, 2020 | www.globenewswire.com

Voyageur Pharmaceuticals Announces its “From The Earth To The Bottle” Iodine Contrast Strategy
February 26, 2020 | www.globenewswire.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CVE
Industry Industrial Metals & Minerals
Sub-IndustryN/A
SectorBasic Materials
Current SymbolCVE:VM
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.voyageurminerals.ca
Phone587-779-6166
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowC$0.00 per share
Price / Cash Flow21.00
Book ValueC$0.01 per share
Price / Book7.92

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares100,752,000
Market CapC$9.57 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Voyageur Pharmaceuticals.

5.0 Community Rank

Outperform Votes
Voyageur Pharmaceuticals has received 43 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Voyageur Pharmaceuticals has received 9 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Voyageur Pharmaceuticals has received 82.69% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Voyageur Pharmaceuticals and other stocks. Vote “Outperform” if you believe VM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VM will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Voyageur Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Voyageur Pharmaceuticals does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Voyageur Pharmaceuticals insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Voyageur Pharmaceuticals is -8.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Voyageur Pharmaceuticals is -8.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Voyageur Pharmaceuticals has a P/B Ratio of 7.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Voyageur Pharmaceuticals (CVE:VM) Frequently Asked Questions

What stocks does MarketBeat like better than Voyageur Pharmaceuticals?

Wall Street analysts have given Voyageur Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Voyageur Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Voyageur Pharmaceuticals' stock been impacted by Coronavirus (COVID-19)?

Voyageur Pharmaceuticals' stock was trading at C$0.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VM shares have increased by 46.2% and is now trading at C$0.10.
View which stocks have been most impacted by COVID-19.

Who are Voyageur Pharmaceuticals' key executives?

Voyageur Pharmaceuticals' management team includes the following people:

Mr. Brent Willis, Pres, CEO & Director (Age 50, Pay $42.5k)
Mr. Bradley Craig Willis P.Eng., Founder, COO & Director (Age 50, Pay $42.5k)
Mr. Ronald Robert Love, Chief Financial Officer

Who are some of Voyageur Pharmaceuticals' key competitors?

Some companies that are related to Voyageur Pharmaceuticals include Xtract Resources (XTR), Nicola Mining (NIM), StrikePoint Gold (SKP), KEFI Gold and Copper (KEFI), Northern Graphite (NGC), Pancontinental Resources (PUC), Metal Tiger (MTR), Omineca Mining and Metals (OMM), Purepoint Uranium Group (PTU), Midnight Sun Mining (MMA), Blue Star Gold (BAU), Brixton Metals (BBB), Strategic Metals (SMD), Nautilus Minerals (NUS) and Prosper Gold (PGX).
View all of VM's competitors.

What other stocks do shareholders of Voyageur Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), The Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS).

What is Voyageur Pharmaceuticals' stock symbol?

Voyageur Pharmaceuticals trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VM."

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Voyageur Pharmaceuticals' stock price today?

One share of VM stock can currently be purchased for approximately C$0.10.

How much money does Voyageur Pharmaceuticals make?

Voyageur Pharmaceuticals has a market capitalization of C$9.57 million.

What is Voyageur Pharmaceuticals' official website?

The official website for Voyageur Pharmaceuticals is www.voyageurminerals.ca.

How can I contact Voyageur Pharmaceuticals?

The company can be reached via phone at 587-779-6166.

This page was last updated on 8/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Voyageur Pharmaceuticals Stock Forecast, Price & News

About Voyageur Pharmaceuticals

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

5.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio